Lagnason, Quinn Ryzle R.

HRN: 21-39-75  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/25/2025
CEFUROXIME 750MG (VIAL)
08/25/2025
08/31/2025
IV
550mg
Q8h
UTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines